The present invention relates to a process for the manufacture of a specific indolinone derivative and a pharmaceutically acceptable salt thereof, namely 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and its monoethanesulfonate, to new manufacturing steps and to new intermediates of this process.
本发明涉及一种特定
吲哚酮衍
生物及其药用可接受盐的制造方法,即3-Z-[1-(4-(N-((4-甲基
哌嗪-1-基)-甲酰基)-N-甲基
氨基)-
苯胺基)-1-苯基亚甲基]-6-甲氧羰基-
2-吲哚酮及其单
乙磺酸盐,以及该过程的新制造步骤和新中间体。